The combination of subcutaneous daratumumab with VRd was approved in July 2024 for induction and consolidation in patients ...

The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.

Hoskinson Health’s rheumatology program offers diagnosis and treatment for autoimmune and arthritis conditions using in-house ...

Astute Analytica stands out as a premier provider of comprehensive Rheumatology Therapeutics Market research reports specifically tailored for the healthcare sector. Our commitment lies in delivering ...

More than 18 million people worldwide suffer from rheumatoid arthritis, including nearly 1.5 million Americans.

TogetherIV is the brain child of two Edina High School students, including one who gets monthly treatments for chronic ...

While the link between TNF inhibitor use during pregnancy/postpartum and serious infection risk was not statistically significant, an increased risk cannot be ruled out.

Rasmussen said Trump's insistence that Greenland - a semi-autonomous Danish territory - should become part of the United States represented the biggest challenge to NATO since its establishment in ...

Epinephrine is a commonly used agent for a variety of indications and clinical scenarios within the emergency department. It is commonly administered during cardiopulmonary arrest and serves as an ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire TerSera’s Infusion Specialty Therapies Business Unit (IST). This strategic ...

BARCELONA, Spain and DEERFIELD, Ill., Jan. 13, 2026 /PRNewswire/ -- ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire TerSera's ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire TerSera's Infusion Specialty Therapies Business Unit (IST). This strategic ...